William Enright
CIK: 0001705564
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 9, 2026BRNS
Barinthus Biotherapeutics plc.
Disposition(D)Indirect728.5K shares- - Sep 9, 2026BRNS
Barinthus Biotherapeutics plc.
Disposition(D)Indirect514.9K shares- - Jun 11, 2026BFRG
BullFrog AI Holdings, Inc.
Award(A)DirectStock Options (Right to Buy)
15K shares- - Sep 25, 2025BFRG
BullFrog AI Holdings, Inc.
Award(A)DirectStock Options (Right to Buy)
15K shares- - Aug 22, 2025BFRG
BullFrog AI Holdings, Inc.
Award(A)Direct2.8K shares- - Aug 22, 2025BFRG
BullFrog AI Holdings, Inc.
Award(A)Direct5.7K shares- - Feb 3, 2025BRNS
Barinthus Biotherapeutics plc.
Award(A)DirectShare Option (Right to Buy)
600K shares- - Sep 26, 2024BFRG,BFRGW
BullFrog AI Holdings, Inc.
Award(A)DirectStock options (right to buy)
15K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 9, 2026 |  BRNS Barinthus Biotherapeutics plc. | Disposition(D) | 728,454 | - | $0 | Indirect |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | Disposition(D) | 514,923 | - | $0 | Indirect |
| Jun 11, 2026 |  BFRG BullFrog AI Holdings, Inc. | Award(A) Stock Options (Right to Buy) | 15,000 | - | - | Direct |
| Sep 25, 2025 | BFRG BullFrog AI Holdings, Inc. | Award(A) Stock Options (Right to Buy) | 15,000 | - | - | Direct |
| Aug 22, 2025 | BFRG BullFrog AI Holdings, Inc. | Award(A) | 2,813 | - | - | Direct |
| Aug 22, 2025 | BFRG BullFrog AI Holdings, Inc. | Award(A) | 5,710 | - | - | Direct |
| Feb 3, 2025 | BRNS Barinthus Biotherapeutics plc. | Award(A) Share Option (Right to Buy) | 600,000 | - | - | Direct |
| Sep 26, 2024 |  BFRG,BFRGW BullFrog AI Holdings, Inc. | Award(A) Stock options (right to buy) | 15,000 | - | - | Direct |
1-8 of 8 transactions
About Enright William
Enright William (SEC CIK 0001705564) files insider reports with the SEC as Chief Executive Officer of Barinthus Biotherapeutics plc. (BRNS) and Director of BullFrog AI Holdings, Inc. (BFRG).
Signal8 holds 6 ownership filings by Enright William (5 Form 4, 1 Form 5), filed between Feb 5, 2025 and Sep 9, 2026. Those filings report 8 transactions, from Sep 26, 2024 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Enright William's filings is in GERMANTOWN, MD.
Recent filings by Enright William
- Sep 9, 2026: Disposition to issuer transactions of BRNS shares (2 lines, Form 4, code D).
- Jun 11, 2026: Grant or award of BFRG derivative securities (Form 4, code A).
- Sep 25, 2025: Grant or award of BFRG derivative securities (Form 4, code A).
- Aug 22, 2025: Grants or awards of BFRG shares (2 lines, Form 4, code A).
- Feb 3, 2025: Grant or award of BRNS derivative securities (Form 4, code A).
Other insiders filing for Barinthus Biotherapeutics plc. (BRNS)
- Oxford Science Enterprises plc, Officer
- Wright Robin, Director
- Scheeren Joseph, Director
- Phillips Anne M., Director
- Morgon Pierre A., Director
- Hooftman Leon, Chief Medical Officer